Platelet aggregation may not be a prerequisite for collagen-stimulated platelet generation of nitric oxide
By determining the sum of the supernatant concentrations of nitrite and nitrate the stimulated generation of nitric oxide (NO) by human washed platelets induced by a range of fibrillar collagen concentrations (0.0156–25 μg ml −1) was investigated. Platelet serotonin (5-hydroxytryptamine, 5-HT) efflu...
Saved in:
Published in | Biochimica et biophysica acta Vol. 1473; no. 2; pp. 286 - 292 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
27.12.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | By determining the sum of the supernatant concentrations of nitrite and nitrate the stimulated generation of nitric oxide (NO) by human washed platelets induced by a range of fibrillar collagen concentrations (0.0156–25 μg ml
−1) was investigated. Platelet serotonin (5-hydroxytryptamine, 5-HT) efflux and platelet aggregation were also measured. Under resting conditions (0 μg ml
−1 collagen) platelet NO release was equivalent to 1.06±0.17 nmol per 10
8 platelets. Maximal NO release, equivalent to 2.1±0.37 nmol per 10
8 platelets, was observed with only 0.0625 μg ml
−1 collagen (
P<0.02, stimulated vs. resting release), higher collagen concentrations producing no further increases in platelet NO output. By contrast, maximal platelet aggregation and 5-HT efflux did not occur until collagen concentrations of 2.5 μg ml
−1 and 10–25 μg ml
−1, respectively, had been achieved.
l-NAME (1 mmol l
−1) and
l-NMMA (1 mmol l
−1) inhibited stimulated platelet NO generation by 78±6% and 72%, respectively. Contrasting with fibrillar collagen, fibrillar β-amyloid protein had no effect on platelet NO generation, or on 5-HT efflux or aggregation. These data perhaps indicate that NO generation by human platelets is stimulated by concentrations of fibrillar collagen insufficient to elicit an aggregatory response. Such a mechanism could operate in vivo to inhibit platelet aggregation which might otherwise be induced by low concentrations of circulating agonists. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0304-4165 0006-3002 1872-8006 1878-2434 |
DOI: | 10.1016/S0304-4165(99)00202-0 |